Profile
Oliver Sol is currently VP & Head-Clinical Development at AC Immune SA since 2016.
Former positions include Clinical Director at Exonhit and Director-Medical & Regulatory Affairs at Eurobio-Scientific SA. Education includes a doctorate from Université de Paris XI Paris Sud.
Oliver Sol active positions
| Companies | Position | Start |
|---|---|---|
| AC IMMUNE SA | Chief Tech/Sci/R&D Officer | - |
Former positions of Oliver Sol
| Companies | Position | End |
|---|---|---|
| EUROBIO SCIENTIFIC | Chief Tech/Sci/R&D Officer | - |
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Develops and manufactures novel pharmaceuticals | Chief Tech/Sci/R&D Officer | - |
Training of Oliver Sol
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
AC Immune SA
AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Develops and manufactures novel pharmaceuticals | Health Technology |
Université de Paris XI Paris Sud
Université de Paris XI Paris Sud Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eurobio-Scientific SA
Eurobio-Scientific SA Medical SpecialtiesHealth Technology Develops and distributes medical diagnosis tool kits | Health Technology |
- Stock Market
- Insiders
- Oliver Sol
















